- Home
- TIL vs LFT Comparison
TIL vs LFT Comparison
Compare TIL & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | LFT |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.8M | 56.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TIL | LFT |
|---|---|---|
| Price | $7.78 | $0.93 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $125.00 | N/A |
| AVG Volume (30 Days) | 15.8K | ★ 223.1K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 18.49% |
| EPS Growth | ★ 6.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $668.15 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.67 | $0.92 |
| 52 Week High | $33.83 | $2.45 |
Technical Indicators
Market Signals| Indicator | TIL | LFT |
|---|---|---|
| Relative Strength Index (RSI) | 50.57 | 37.34 |
| Support Level | $7.51 | N/A |
| Resistance Level | $8.25 | $1.40 |
| Average True Range (ATR) | 0.30 | 0.05 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 60.27 | 10.11 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.